Walgreens

Новости

Reuters - 1 неделю назад

Pharmacy chain Walgreens Boots Alliance to cut corporate jobs by 10%

Pharmacy chain Walgreens Boots Alliance to cut corporate jobs by 10% May 26 (Reuters) - Walgreens Boots Alliance Inc WBA.O said on Friday it would slash its corporate staff by about 10%, as it streamlines operations and focuses on consumer-facing healthcare businesses. None of the 504 roles being cut are based at its stores, micro-fulfillment outlets or call centers, a company spokesperson told Reuters.

Reuters - 1 неделю назад

Walgreens Announces Decision To Eliminate 504 Roles, Accounting For 10% Of Corporate Workforce

BRIEF-Walgreens Announces Decision To Eliminate 504 Roles, Accounting For 10% Of Corporate Workforce May 26 (Reuters) - Walgreens Boots Alliance Inc WBA.O : WALGREENS - DECISION TO ELIMINATE 504 ROLES, WHICH ACCOUNT FOR 10% OF OUR CORPORATE WORKFORCE WALGREENS - NONE OF ELIMINATED ROLES ARE BASED AT OUR STORES, MICROFULFILLMENT CENTERS OR CALL CENT

Reuters - 2 недель назад

Walgreens fights 'staggering' $642 mln arbitration award to Humana

Walgreens fights 'staggering' $642 mln arbitration award to Humana Pharmacy chain raises conflict question about Humana's law firm Humana seeks confirmation of award, in dispute over drug price reimbursement By Mike Scarcella May 22 (Reuters) - National retail pharmacy giant Walgreen Co has asked a U.S. judge to vacate an arbitrator's award of more than $642 million to Humana Health Plan Inc in a drug-pricing dispute, calling the "staggering" sum the result of a "miscarriage of justice." Lawyers

Reuters - 2 недель назад

Walgreens reaches $230 mln opioid settlement with San Francisco

UPDATE 3-Walgreens reaches $230 mln opioid settlement with San Francisco Adds previous Walgreens settlement with Florida in paragraph 12, closing stock price in paragraph 15 By Jonathan Stempel May 17 (Reuters) - San Francisco said on Wednesday it reached a $230 million settlement with Walgreens Boots Alliance Inc WBA.O over its role in the city's opioid epidemic.

Reuters - 2 недель назад

Walgreens reaches $230 mln opioid settlement with San Francisco

Walgreens reaches $230 mln opioid settlement with San Francisco May 17 (Reuters) - Walgreens WBA.O has reached a $230 million settlement with San Francisco over its alleged role in that city's opioid epidemic, city attorney David Chiu said on Wednesday. Chiu said in Twitter posts the accord followed a trial where the court found Walgreens substantially contributed to the epidemic and created a public nuisance.

Reuters - 3 недель назад

Adage Capital Partners Gp Llc Takes Share Stake In 3M, Manchester United; Dissolves in Ferrari, Walgreens

BRIEF-Adage Capital Partners Gp Llc Takes Share Stake In 3M, Manchester United; Dissolves in Ferrari, Walgreens May 15 (Reuters) - Adage Capital Partners GP LLC: ADAGE CAPITAL PARTNERS GP LLC TAKES SHARE STAKE OF 40,214 SHARES IN 3M CO SHARES ADAGE CAPITAL PARTNERS GP LLC CUTS SHARE STAKE IN BANK OF AMERICA CORP BY 22.2% TO 3.8 MILLION SHARES ADAG

Reuters - 3 недель назад

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Korean Air Lines, Saras, EQT Infrastructure May 12 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1 945 GMT on Friday: * * Korean Air Lines 003490.KS expects EU antitrust regulators to issue a formal warning about its bid for Asiana Airlines 020560.KS by the end of May, South Korea's biggest carrier said, raising yet another hurdle for a major deal in the aviation industry.

Reuters - 3 недель назад

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: SiriusPoint, Volvo Updates, SBI Holdings Inc May 12 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Friday: ** Billionaire investor Daniel Loeb is no longer exploring a potential acquisition of SiriusPoint SPNT.N , according to a regulatory filing, a month after disclosing his interest in taking the insurance firm private.

Reuters - 3 недель назад

Walgreens sells some AmerisourceBergen shares for $694 mln

Walgreens sells some AmerisourceBergen shares for $694 mln May 11 (Reuters) - Walgreens Boots Alliance WBA.O , one of the largest U.S. pharmacies, said on Thursday it has sold some of its shares in drug distributor AmerisourceBergen Corp ABC.N for $694 million and will primarily use the proceeds to pay down debt. AmerisourceBergen will repurchase about $50 million of its common stock from Walgreens in this transaction, the U.S.

Reuters - 3 недель назад

Walgreens Boots Alliance Sells Shares Of Amerisourcebergen Corporation For $694 Million Of Initial Proceeds

BRIEF-Walgreens Boots Alliance Sells Shares Of Amerisourcebergen Corporation For $694 Million Of Initial Proceeds May 11 (Reuters) - Walgreens WBA.O : BOOTS ALLIANCE SELLS SHARES OF AMERISOURCEBERGEN CORPORATION FOR $694 MILLION OF INITIAL PROCEEDS PROCEEDS TO WALGREENS BOOTS ALLIANCE WILL BE USED PRIMARILY FOR DEBT PAYDOWN AND GENERAL CORPORATE PU

Reuters - 4 недель назад

CVS Health to pause M&A and focus on integration

UPDATE 6-CVS Health to pause M&A and focus on integration Adds CEO comments on COVID products in paragraph 6, 7 By Raghav Mahobe and Leroy Leo May 3 (Reuters) - CVS Health Corp CVS.N said on Wednesday it would pause its recent acquisition spree as it focuses on integrating purchases of healthcare service provider Signify Health and primary care provider Oak Street Health .

Reuters - 1 месяц назад

Wall Street Journal - May 1

PRESS DIGEST - Wall Street Journal - May 1 May 1 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - The Federal Deposit Insurance Corp is reviewing bids for First Republic Bank FRC.N and preparing to seize the lender. - Texas law enforcement expanded its search over the weekend for a gunman accused of fatally shooting five people, including an 8-year-old child.

Reuters - 1 месяц назад

Walgreens Boots Declares Qtrly Dividend Of 48 Cents Per Share

BRIEF-Walgreens Boots Declares Qtrly Dividend Of 48 Cents Per Share April 20 (Reuters) - Walgreens Boots Alliance Inc WBA.O : WALGREENS BOOTS ALLIANCE DECLARES QUARTERLY DIVIDEND WALGREENS - HAS DECLARED A QUARTERLY DIVIDEND OF 48 CENTS PER SHARE Source text for Eikon: ID:nBw6bPWdha Further company coverage: WBA.O

Reuters - 2 месяцев назад

U.S. STOCKS Groupon, Hecla Mining, Harley-Davidson

BUZZ-U.S. STOCKS ON THE MOVE-Groupon, Hecla Mining, Harley-Davidson Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes rose on Thursday as a moderation in producer price inflation and jump in weekly jobless claims brought relief to investors worried about how far the Federal Reserve will hike interest rates to tame surging prices.

Reuters - 2 месяцев назад

Walgreens And Prothena Partner To Increase Access And Enrollment In Alzheimer's Disease Clinical Trial

BRIEF-Walgreens And Prothena Partner To Increase Access And Enrollment In Alzheimer's Disease Clinical Trial April 13 (Reuters) - Walgreens: WALGREENS AND PROTHENA PARTNER TO INCREASE ACCESS AND ENROLLMENT IN ALZHEIMER'S DISEASE CLINICAL TRIAL WALGREENS - PROTHENA'S PHASE 1 PRX012 SINGLE ASCENDING DOSE & MULTIPLE ASCENDING DOSE STUDIES ONGOING WITH

Reuters - 2 месяцев назад

Biden administration abortion rule seeks to protect women crossing state lines

Biden administration abortion rule seeks to protect women crossing state lines By Jarrett Renshaw and Ahmed Aboulenein April 12 (Reuters) - The U.S. Department of Health and Human Services (HHS) on Wednesday will propose a new rule prohibiting healthcare providers and insurers from sharing private health information if that information will be used to investigate someone for accessing or providing reproductive care, including abortion.

Reuters - 2 месяцев назад

White House plans support for drugstores, pharma in abortion pill battle -sources

UPDATE 1-White House plans support for drugstores, pharma in abortion pill battle -sources Adds comments from a senior U.S. administration official and Walgreens By Nandita Bose WASHINGTON, April 9 (Reuters) - The White House is planning to re-up discussions with abortion pill manufacturers and U.S. pharmacy chains on ways to push back against efforts to ban mifepristone, two sources with knowledge of the matter said, as it a ppeals a Texas court ruling suspending the approval of the drug.

Reuters - 2 месяцев назад

White House plans support for drugstores, pharma in abortion pill battle -sources

White House plans support for drugstores, pharma in abortion pill battle -sources By Nandita Bose WASHINGTON, April 9 (Reuters) - The White House is re-upping discussions with abortion pill manufacturers and U.S. pharmacy chains on ways to push back against efforts to ban mifepristone, two sources with knowledge of the matter said, as it gears up to appeal a Texas court ruling suspending the approval of the drug.

Reuters - 2 месяцев назад

California oil bill is industrial policy, refined

BREAKINGVIEWS-California oil bill is industrial policy, refined The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Ben Winck WASHINGTON, March 30 (Reuters Breakingviews) - Americans spending the most on fuel have a new ally in the California government. Democratic Governor Gavin Newsom signed legislation on Tuesday that will create a new watchdog for companies that refine oil and penalize those reaping oversized profits.

Reuters - 2 месяцев назад

U.S. STOCKS Energy firms, nickel stocks, gold miners

BUZZ-U.S. STOCKS ON THE MOVE-Energy firms, nickel stocks, gold miners Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street struggled for direction on Tuesday as investors weighed receding concerns about a banking crisis, while Treasury yields rose amid focus on Federal Reserve's interest rate trajectory.

Условия

Попул. активы

Правовая оговорка: Компании группы XM Group предоставляют только услуги по исполнению сделок и доступ к нашей торговой онлайн-среде, в которой пользователи могут просматривать и (или) пользоваться материалами, доступными на вебсайте либо доступными по ссылкам с данного сайта на другие. Предоставление доступа к онлайн-среде не меняет сути предоставляемых услуг и не расширяет их. Такой доступ и пользование материалами предоставляются с учетом:(i) «Условий и положений»; (ii) «Предупреждений о рисках» и (iii) полного текста «Правовой оговорки». Следовательно, подобные материалы предоставляются лишь в качестве информации общего характера. В частности, просим Вас иметь в виду, что материалы, содержащиеся в нашей торговой онлайн-среде, не являются ни просьбой осуществить какие-либо транзакции на финансовых рынках, ни предложением к осуществлению подобных транзакций. Торговля на любом финансовом рынке подразумевает большой риск потери Вашего капитала.

Все материалы, опубликованные в нашей торговой среде, предоставляются только в образовательных или информационных целях и не содержат (и не должны рассматриваться как содержащие) финансовых, инвестиционных или торговых рекомендаций, а также информации о стоимости наших услуг по предоставлению доступа к рынкам, либо предложения или содействия в проведении транзакций по какому-либо финансовому инструменту или по незапрашиваемым финансовым услугам по отношению к Вам.

Любые материалы на данном вебсайте, созданные третьими лицами, а также материалы, подготовленные XM, такие как мнения экспертов, новости, исследования, анализ, котировки и другая информация, а также ссылки на сторонние сайты предоставляются в виде «как есть», как рыночная информация общего характера, и не являют собой рекомендации по инвестициям. Принимая во внимание то, что любые материалы рассматриваются как инвестиционное исследование, Вам следует учесть и принять тот факт, что никакие материалы не подготавливались и не предназначались к использованию в соответствии с правовыми нормами, способствующими независимости инвестиционных исследований. Следовательно, материалы следует рассматривать как материалы рекламного характера согласно соответствующим законам и правовым нормам. Рекомендуем Вам прочесть и уяснить для себя положения наших «Уведомления о субъективном инвестиционном исследовании» и «Предупреждения о рисках» в отношении приведённой выше информации. С этими документами можно ознакомиться здесь.

Walgreens

Новости

Условия

Попул. активы

Чат XM